Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Picoentech Co. Ltd. has a focused presence in the Biotechnology & Pharmaceuticals technology area with 1 pending office action currently on record. This single action is being handled by a distinct examiner within a distinct art unit, with each category totaling 1, representing a highly concentrated and specific point of prosecution activity for the company.
JONES-FOSTER, ERICA NICOLE is the busiest examiner for the portfolio, as she is responsible for the pending office action. Because there is only a single pending action in total, this examiner manages the entirety of the company's current pending workload. This creates a direct relationship between the company's immediate patent prospects and the review of this specific official.
The alignment of prosecution within the Biotechnology & Pharmaceuticals sector simplifies the landscape. Practitioners can focus their efforts entirely on the specific standards and practices of the unit where JONES-FOSTER, ERICA NICOLE operates. This singular focus allows for a targeted approach to resolving the outstanding matter.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JONES-FOSTER, ERICA NICOLE | 1 | 48.1% | +44.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18519546 | FOOD AND PHARMACEUTICAL COMPOSITION CONTAINING NOVEL ALDEHYDE DEHYDROGENASE FOR IMPROVING MEMORY AND COGNITIVE FUNCTION | JONES-FOSTER, ERICA NICOLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18519546 | FOOD AND PHARMACEUTICAL COMPOSITION CONTAINING NOVEL ALDEHYDE DEHYDROGENASE FOR IMPROVING MEMORY AND COGNITIVE FUNCTION | JONES-FOSTER, ERICA NICOLE | — |
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18519546 | FOOD AND PHARMACEUTICAL COMPOSITION CONTAINING NOVEL ALDEHYDE DEHYDROGENASE FOR IMPROVING MEMORY AND COGNITIVE FUNCTION | JONES-FOSTER, ERICA NICOLE | 1656 | §101§102§103§112DP | Non-Final OA | — | Pending | Nov 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial